A novel DPP10 (intergenic)-NTRK3 fusion in a patient with facial malignant melanoma and potentially benefit from NTRK inhibitors.
作者信息
Wei Dongliang, Chen Dongsheng, Li Si, Xiao Mingzhe, Ren Guoxin
机构信息
Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 210000, China.
The State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing 210002, China.
出版信息
Oral Oncol. 2021 Sep;120:105288. doi: 10.1016/j.oraloncology.2021.105288. Epub 2021 Apr 10.
Abstract
摘要
Zotero 插件